Sign in
AFMD Stock Price, Chart, Stats & News
Affimed N.V.
Save
2.98M
Market cap
–
Current P/E
–
Forward P/E
AFMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1288.95% |
Pretax margin | -1280.18% |
Net margin | -1280.22% |
Effective tax rate | -0.00% |
ROA | -109.04% |
ROE | -100.55% |
D/E | 0.33x |
Interest coverage ratio | -59.06x |
AFMD valuation
P/E | – |
P/S | 0.31x |
P/B | 0.04x |
P/CF | -0.02x |
P/FCF | -0.02x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -0.21x |
About
Affimed N. V. operates as a clinical-stage biopharmaceutical enterprise, concentrating its efforts on the identification and advancement of innovative cancer immunotherapies across the United States, Germany, and the broader European region. A key asset in their development pipeline is AFM13.
Similar securities
Based on sector and market capitalization
Report issue